A new treatment strategy for mid-low rectal cancer patients exhibiting a clinical complete or near-complete response to neoadjuvant chemoradiotherapy: Transanal endoscopic microsurgery --A multicenter prospective case-control clinical trial by MONT-R.

European journal of cancer (Oxford, England : 1990) 2025 Vol.216() p. 115156

Qiu X, Zhou J, Qiu H, Shen Z, Wu B, Jia W, Niu B, Li F, Yao H, Wu A, Hu K, Xue H, Zhong G, Zhou W, Chen W, Li G, Lin G

관련 도메인

Abstract

[BACKGROUND] Total mesorectal excision is the standard surgery for locally advanced rectal cancer (LARC) after neoadjuvant chemoradiotherapy (nCRT), but it may lead to high complication rates and poor quality of life. This study evaluates whether transanal endoscopic microsurgery (TEM), as a partial resection procedure, can enhance quality of life for clinical complete response (cCR) or near-cCR patients without compromising survival.

[METHODS] Between May 2017 to September 2021, 80 patients with T3-4N0M0 or TanyN+M0 mid-low rectal cancer achieving cCR or near-cCR post-nCRT were prospectively included at 6 Chinese centers. Patients underwent either TEM (Group A, n = 38) or radical surgery (Group B, n = 41). Clinicopathological, oncological, and functional outcomes were analyzed.

[RESULTS] Postoperative histology revealed 22 ypT0 (57.9 %), 5 ypT1 (13.2 %), 10 ypT2 (26.3 %), and 1 ypT3 (2.6 %) cases in group A and 20 pCR (48.8 %), 1 T0N1 (2.4 %), 5 T1N0 (12.2 %), 12 T2-3N0 (29.3 %), 3 T2-3N1 (7.3 %) cases in group B. After a 60-month median follow-up, local recurrence occurred in 2 patients (5.26 %) in Group A and none in Group B. Distant metastases occurred in 8 patients (21.05 %) in group A and 7 (17.07 %) in group B. There was no significant difference between the two groups in 5-year disease-free survival (P = 0.658) or 5-year overall survival (P = 0.465). Group A showed significantly faster recovery (P < 0.001) and better sphincter function per Wexner (1 vs. 4, P = 0.001) and LARS (0 vs. 17, P < 0.001) scores than Group B.

[CONCLUSION] TEM may be an effective approach for assessing residual tumors in LARC patients with cCR or near-cCR. This approach offers an option for those requiring sphincter preservation, with no significant compromise in long-term oncological outcomes observed in our study.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 microsurgery 미세수술 dict 2
기법 endoscopic 내시경 dict 2
약물 LARC → locally advanced rectal cancer C0677984
Locally Advanced Malignant Neoplasm
scispacy 1
약물 nCRT → neoadjuvant chemoradiotherapy C5392215
Neoadjuvant Chemoradiotherapy
scispacy 1
약물 T3-4N0M0 scispacy 1
약물 post-nCRT scispacy 1
약물 [BACKGROUND] Total mesorectal excision is scispacy 1
약물 [CONCLUSION] TEM scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 tumors C0027651
Neoplasms
scispacy 1
질환 rectal cancer patients scispacy 1
질환 rectal cancer scispacy 1
질환 T3- scispacy 1
질환 T0N1 scispacy 1
기타 patients scispacy 1

MeSH Terms

Adult; Aged; Female; Humans; Male; Middle Aged; Case-Control Studies; Chemoradiotherapy, Adjuvant; Neoadjuvant Therapy; Prospective Studies; Quality of Life; Rectal Neoplasms; Transanal Endoscopic Microsurgery; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문